Over half of KCNMA1-linked channelopathy patients harbor variants that have been shown to change BK current levels and properties, and in this section, we review the evidence supporting the gain of function (GOF), loss of function (LOF), and putative benign designations with respect to BK channel activity. The gene discussed is KCNMA1; the disease is channelopathy.